X

Health & Biotech

ASX Health Stocks: Little Green Pharma’s cannabis to set sail from Denmark to Italy after tender win

At the time of writing, the ASX 200 Health Index (XHJ) is down by 2.3%, while the benchmark ASX 200…

ASX Health Stocks: Amplia Therapeutics gains momentum on pancreatic cancer drug

At the time of writing, the ASX 200 Health Index (XHJ) is up by another 3.3%, while the benchmark ASX…

Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The…

Off and running: Chemist Warehouse to distribute Wellnex JV’s market-topping range of organic A2 infant formula

The joint venture has formally secured countrywide distribution through Australia’s largest pharmacy giant, Chemist Warehouse. But we’ll get to that…

ASX Health Stocks: Healthcare index surges as CSL revels in blood plasma boom

At the time of writing, the ASX 200 Health Index (XHJ) is up by over 4%, while the benchmark ASX…

EZZ launching new hangover recovery & weight management products

Special Report:  From a hangover remedy to weight management, EZZ is expanding its product range to gain a foothold in…

PharmAust turning e-waste into dollars as lucrative mining recovery revenue beckons

Special Report: Epichem’s successful e-waste project could create new revenue streams for PharmAust, as it eyes the lucrative waste and…

Why Nanollose is on the verge of a major market opportunity with its fibre conversion technology, as global fashion brands come knocking

Special Report: Nanollose is on the cusp of a transformative year, with its revolutionary technology that converts fermented waste into…

The UK’s love affair with Aussie medicinal cannabis blooms as ECS exports first dried flower shipment

Special Report: It’s a happy Valentine for the team at ECS, as the Aussie medicinal cannabis group successfully exports Australia’s…

ASX Health Stocks: Opthea presents data at global conference; CardieX to progress Philip Morris sponsored study

At the time of writing, the ASX 200 Health Index (XHJ) is down 1%, while the benchmark ASX 200 is…